Abstract: A new system for detection of polymeric immunoglobulin A (pIgA)-polymeric immunoglobulin receptor (pIgR) binding was established. Cell lysates of a mouse pIgR cDNA transfectant, 2S9
Introduction
The polymeric immunoglobulin receptor (pIgR), a transmembrane glycoprotein localized on glandular epithelial cells, functions as a receptor for polymeric immunogloblins (pIg) (1) . The extracellular portion of pIgR binds to pIg, which is produced and secreted by plasma cells at the submucosal site of glandular tissues, and transports pIg across epithelial cells to the external secretions (2) . The extracellular portion of pIgR is composed of five immunoglobulin-like domains. The most N-terminal domain (the first domain) of pIgR plays an important role in the binding of its cognate ligand, polymeric immunoglobulin A (pIgA) (3) (4) (5) (6) (7) . In addition to this region, several reports have indicated that the fifth domain of pIgR may also play an intrinsic role in pIgA binding (8) .
Although pIgR has been reported to be a highly glycosylated molecule, the role of the sugar side chains has remained elusive. Bakos et al. (5) reported that N-linked carbohydrate moieties on the free secretory component (FSC) were not required for pIg binding. Moreover, E. coli expressed-fusion proteins containing the first domain of pIgR, which would contain very few carbohydrate side chains, inhibited pIgA-pIgR binding (7) . These observations demonstrated that the glycosylation site of domain I of the pIgR molecule was not necessary for pIgA-pIgR binding. However, there exist other N-glycosylation sites on the pIgR molecule whose contribution to the pIgA-pIgR interaction remains unknown. In this report, a novel pIgA-pIgR binding assay system was established using a mouse pIgR cDNA transfectant, 259.1, developed previously in our laboratory (8) 
Results
Establishment of the pIgA-pIgR binding assay In order to establish a new assay system to investigate the pIgA-pIgR interaction, 259.1 cell lysates were incubated with MOPC 315, MOPC 21 or PBS. As shown in Fig. 1 , the lysates incubated with MOPC 315 (lane 1) clearly showed a positively stained band of 120 kDa. On the other hand, the lysates incubated with MOPC 21 (lane 2) or with PBS (lane 3) gave no 120-kDa positive bands. The lower bands observed in the three lanes were considered to be non-specific bands, as these bands were present even when no immunoglobulin molecule was added to the cell extracts. The cell lysates of mock transfectant, 3N1, did not show any positive band when incubated with MOPC 315 or MOPC 21 (data not shown). Furthermore, the 120-kDa band observed in lane 1 disappeared completely when the membrane was incubated with a control antibody as the first antibody (data not shown). These results clearly indicated the binding of pIgA to pIgR in vitro, and that the present system could be used to detect pIgA-pIgR interaction using the mouse pIgR cDNA transfectant, 2S9.1. Using this system, the influence of tunicamycin treatment, which blocks N-glycosylation of pIgR upon pIgA-pIgR binding, was examined.
pIgR free of N-glycosylation can bind to pIgA Previously, it was shown that the molecular weight of pIgR decreased to 100 kDa after tunicamycin treatment of 2S9.1 cells (8), indicating that the unmodified form of pIgR must be 100 kDa in size. In order to examine if the unmodified form of pIgR can bind to pIgA, 2S9.1 cells were cultured in the presence or absence of tunicamycin, and the pIgA-pIgR binding assay was performed. As shown in Fig. 2 , the 100-kDa band was clearly visible in lane 1 when the 2S9.1 cells were cultured in the presence of tunicamycin. In addition to this band, a residual 120-kDa band could also be observed (lane 1). This band probably represents the pIgR molecules produced before tunicamycin treatment. Although the 110-kDa band was absent from lane 1, both 120-and 110-kDa bands were clearly observed in lane 2. The amount of the 110-kDa molecule was quantitatively smaller than that of the 120-kDa band (8) , and this partially glycosylated molecule is probably that which is most affected by tunicamycin treatment. Taken together, these results indicated that pIgR molecules lacking N-glycosylation could still bind to pIgA. In other words, N-glycosylation of pIgR does not contribute to pIgA binding by pIgR.
Discussion
Plasma cells homing back from a Peyer's patch to mucosal effector sites, such as the interstitial tissues of salivary glands, secrete pIgA (2) . At first, the secreted pIgA binds noncovalently to pIgR localized on the basolateral membranes of glandular tissues, but later binds covalently to pIgR. It has been reported that the apparent association constant (Ka) of pIgA with free SC in solution is approximately 108 M-1, which corresponds to that of a typical antigen-antibody reaction (9) . A Ka of about 109 M-1 was also suggested by Kuhn et al. for the interaction between the SC-expressing cell and pIgA (10) .
In this paper, I have described the establishment of a new assay system for detection of pIgA-pIgR binding in vitro. Although there have been several reports concerning the pIgA-pIgR interaction, the present one describes a system which allows the assay of pIgA-pIgR binding using pIgR expressed from a cDNA in mouse cells. Hence, the system may be useful for research on pIgA-pIgR interaction.
It is generally agreed that the first N-terminal region of pIgR is highly conserved among several mammalian species (11) (12) (13) (14) (15) (16) and that it plays an intrinsic role in pIgpIgR binding (3) (4) (5) (6) (7) . In addition to this region, the fifth domain of pIgR also contributes to pIgA-pIgR binding by allowing the formation of covalent bonds (11) . However, these reports were based mainly on enzymatic methods, and as a consequence, the experimental systems employed partially cleaved fragments of pIgR. The newly established assay system described here uses cells transfected with a cDNA encoding the entire pIgR molecule. Thus, this system will allow more physiological studies of the interaction between the entire pIgR molecule and pIgA. Although in some cases, such as in neuronal channels, N-linked glycosylation plays an important biological function (17) , the importance of the sugar side chains of pIgR is still obscure. Bakos et al. (5) , using the enzymatically deglycosylated free secretory component molecule, clearly demonstrated that the N-linked carbohydrate of domain I on human free secretory component was not required for specific binding to pIgA. Moreover, an E. coli expressed-fusion protein containing the first domain of human pIgR, which would contain very little carbohydrate, was still able to inhibit specific pIgA-pIgR binding and bind directly to pIg with reduced affinity (7) . In the present study, a mouse pIgR transfectant was utilized to molecular maturation of pIgR (8) , and this made it possible to estimate directly the molecular weights of pIgA-binding pIgR molecules.
Tunicamycin, a well known N-glycosylation inhibitor, reduced the molecular weight of the pIgR molecule to 100 kDa from 120 kDa, but had little effect on pIgA binding. This result suggests that the completely deglycosylated pIgR molecule still retains the ability to bind to pIgA, and that N-linked glycosylation of pIgR is unnecessary for pIg binding. Although protein G-Sepharose was used to precipitate pIgA in this study, this system should be useful for assaying certain pIgA-interactive molecules.
Conclusion
Using a mouse pIgR cDNA transfectant, 2S9.1, developed in our laboratory, a new system for detection of pIgA-pIgR interaction has been established. The system relies on the incubation of lysates of the 2S9.1 transfectant with MOPC 315 (pIgA) or MOPC 21 (IgG) proteins. After precipitation of the immunocomplexes with protein -G-Sepharose , the bound proteins were blotted with a polyclonal anti-mouse pIgR antibody. The mouse pIgR molecule was precipitated along with pIgA, indicating successful detection of the pIgA-pIgR complex. The role of N-glycosylation in the pIgR-pIgA interaction was examined after tunicamycin treatment of the 2S9.1 transfectant. The complete deglycosylation of pIgR did not affect binding of pIgA by pIgR, suggesting that Nglycosylation of the pIgR molecule is unnecessary for pIgA-pIgR binding. This system should be useful for the detection of pIgA-pIgR binding.
